ACSL3 is a potential prognostic biomarker for immune infiltration in clear cell renal cell carcinoma
ObjectiveLong-chain acyl-coenzyme A synthases (ACSLs) catalyze the activation of fatty acid and are often dysregulated in malignancies. The purpose of this research was to figure out the ACSL3's prognostic value and mechanism in clear cell renal cell carcinoma (ccRCC).MethodsThe expression of A...
Main Authors: | Chiyu Zhang, Honglin Hu, Ruizhen Huang, Gaomin Huang, Xiaoqing Xi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Surgery |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fsurg.2022.909854/full |
Similar Items
-
The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma
by: Yang Yang, et al.
Published: (2023-08-01) -
Overexpression of DBT suppresses the aggressiveness of renal clear cell carcinoma and correlates with immune infiltration
by: Chiyu Zhang, et al.
Published: (2023-06-01) -
ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma
by: Timothy D. Klasson, et al.
Published: (2022-10-01) -
SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma
by: Huayi Feng, et al.
Published: (2022-12-01) -
The Diagnostic Value of ACSL1, ACSL4, and ACSL5 and the Clinical Potential of an ACSL Inhibitor in Non-Small-Cell Lung Cancer
by: Yunxia Ma, et al.
Published: (2024-03-01)